OL
GSK icon

Optas LLC’s GSK GSK Stock Holding History

Optas LLC’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$211K Buy
4,032
+254
+7% +$13.4K 0.03% 438
2026
Q1 		$209K Sell
3,778
-317
-8% -$17.2K 0.03% 441
2025
Q4 		$201K Buy
+4,095
New +$191K 0.03% 435
2022
Q3 		– Sell
-6,802
Closed -$370K – 140
2022
Q2 		$370K Buy
6,802
+452
+7% +$25K 0.15% 91
2022
Q1 		$345K Buy
6,350
+80
+1% +$4.34K 0.11% 105
2021
Q4 		$345K Sell
6,270
-4
-0.1% -$208 0.1% 115
2021
Q3 		$300K Buy
6,274
+495
+9% +$24.9K 0.09% 115
2021
Q2 		$287K Buy
5,779
+72
+1% +$3.46K 0.08% 116
2021
Q1 		$255K Buy
+5,707
New +$259K 0.08% 121

Other funds holding GSK

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
DLA
Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return
TNB
Thomasville National Bank Thomasville, Georgia $1.82B AUM
AA
ABC Arbitrage Paris, France $926M AUM 45.9% 1-Year Est. Return
FVWA
Foster Victor Wealth Advisors Greenville, South Carolina $1.9B AUM 24.46% 1-Year Est. Return
SIS
Sound Income Strategies Ft Lauderdale, Florida $2.23B AUM 11.22% 1-Year Est. Return
KFP
Keystone Financial Planning Cleveland, Ohio $388M AUM 16.66% 1-Year Est. Return
QCM
QRG Capital Management Chicago, Illinois $12.1B AUM 44.98% 1-Year Est. Return
TH
Transmarket Holdings Chicago, Illinois $136M AUM
GC
Grimes & Company Westborough, Massachusetts $4.62B AUM 29.71% 1-Year Est. Return

Optas LLC's GSK Position: Q2 2026 in Review

Optas LLC increased its GSK (GSK) stake by 6.7% in Q2 2026, buying an estimated $13.4K and bringing the position to 4,032 shares worth $211K. The position accounts for 0.03% of the portfolio, ranked #438.

Optas LLC first reported a position in GSK in Q1 2021 and has held it in 9 quarters since. The position peaked at $370K in Q2 2022. 268 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Optas LLC held 4,032 shares of GSK worth $211K as of Q2 2026.
  • Optas LLC bought 254 GSK shares in Q2 2026, an estimated $13.4K.
  • GSK made up 0.03% of Optas LLC's portfolio in Q2 2026, its #438 holding.
  • Optas LLC first reported a position in GSK in Q1 2021 and has held it in 9 quarters since.
  • Optas LLC's GSK position peaked at $370K in Q2 2022.
  • 268 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Optas LLC's 13F filing for Q2 2026, filed 21 Jul 2026.